FALLOPIAN TUBE NEOPLASMS
Clinical trials for FALLOPIAN TUBE NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new FALLOPIAN TUBE NEOPLASMS trials appear
Sign up with your email to follow new studies for FALLOPIAN TUBE NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Ovarian cancer hope: immunotherapy combo shows promise in Tough-to-Treat cases
Disease control OngoingThis study tests whether adding the immunotherapy drug pembrolizumab to standard chemotherapy (paclitaxel, with or without bevacizumab) can slow the growth of ovarian cancer that has stopped responding to platinum-based treatments. About 643 adults with this type of ovarian cance…
Matched conditions: FALLOPIAN TUBE NEOPLASMS
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 26, 2026 09:51 UTC
-
New drug combo shows promise in ovarian cancer fight
Disease control OngoingThis study tests whether adding the immunotherapy drug oregovomab to standard chemotherapy can help people with advanced ovarian, fallopian tube, or peritoneal cancer. About 88 newly diagnosed patients will receive either the drug combo or chemo alone before and after surgery. Th…
Matched conditions: FALLOPIAN TUBE NEOPLASMS
Phase: PHASE2 • Sponsor: CanariaBio Inc. • Aim: Disease control
Last updated May 26, 2026 09:48 UTC
-
New drug combo could slow ovarian Cancer's return
Disease control OngoingThis study tests whether adding the immunotherapy drug oregovomab to standard chemotherapy can help people with advanced ovarian cancer live longer without their cancer growing. About 615 newly diagnosed patients who had surgery to remove most of their cancer will receive either …
Matched conditions: FALLOPIAN TUBE NEOPLASMS
Phase: PHASE3 • Sponsor: CanariaBio Inc. • Aim: Disease control
Last updated May 18, 2026 12:07 UTC